CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 89 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,305,661 | -74.7% | 60,012 | -84.8% | 0.01% | -94.2% |
| Q1 2023 | $9,123,415 | +165.1% | 394,100 | +200.0% | 0.14% | +117.5% |
| Q4 2022 | $3,442,025 | -41.1% | 131,375 | -55.8% | 0.06% | -43.8% |
| Q3 2022 | $5,847,000 | +20.9% | 297,384 | +7.5% | 0.11% | -15.8% |
| Q2 2022 | $4,837,000 | +70.4% | 276,538 | +59.4% | 0.13% | +75.0% |
| Q1 2022 | $2,839,000 | -1.4% | 173,503 | -1.7% | 0.08% | -14.6% |
| Q4 2021 | $2,880,000 | +1130.8% | 176,551 | +965.7% | 0.09% | +1012.5% |
| Q2 2021 | $234,000 | – | 16,567 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |